MMWR Weekly: Current Volume (73)
December 12, 2024 / No. 49
- Epidemiology of Dengue — Puerto Rico, 2010–2024
- Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
- New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
- Progress Toward Poliomyelitis Eradication — Afghanistan, January 2023–September 2024
December 5, 2024 / No. 48
- Intimate Partner Violence and Pregnancy and Infant Health Outcomes — Pregnancy Risk Assessment Monitoring System, Nine U.S. Jurisdictions, 2016–2022
- Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024
- Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024
- Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
- QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years with Hypertension, by Sex and Race and Ethnicity — United States, August 2021–August 2023
- Severe and Fatal Rocky Mountain Spotted Fever After Exposure in Tecate, Mexico — California, July 2023–January 2024
- Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024
- Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023
- Notes from the Field: Human Parvovirus B19 Infections Among Pregnant Persons — Minnesota, January–September 2024
- Notes from the Field: Increase in Diagnoses of Human Parvovirus B19–Associated Aplastic Crises in Children and Adolescents with Sickle Cell Disease — Atlanta, Georgia, December 14, 2023–September 30, 2024
November 21, 2024 / No. 46
- Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2024
- Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
- Detection of Real-Time Changes in Direction of COVID-19 Transmission Using National- and State-Level Epidemic Trends Based on Rt Estimates — United States Overall and New Mexico, April–October 2024
- Notes from the Field: Trends in Emergency Department Visits for Firearm Injuries — United States, January 2018–December 2023
- QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years with Diagnosed Chronic Obstructive Pulmonary Disease, by Urbanization Level — United States, 2023
November 14, 2024 / No. 45
- Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024
- Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications — United States, 2023–2024
- Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results — American Samoa, March–July 2023
- Progress Toward Measles Elimination — Worldwide, 2000–2023
November 7, 2024 / No. 44
- Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
- Personal Protective Equipment Use by Dairy Farmworkers Exposed to Cows Infected with Highly Pathogenic Avian Influenza A(H5N1) Viruses — Colorado, 2024
- Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers — Michigan and Colorado, June–August 2024
- Notes from the Field: Ketamine Detection and Involvement in Drug Overdose Deaths — United States, July 2019–June 2023
- QuickStats: Percentage of Children and Adolescents Aged 12–17 Years Who Participated in 60 Minutes of Physical Activity Most Days or Every Day, by Daily Hours of Screen Time Use — United States, July 2021–December 2023
- Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period — Suzhou City, Jiangsu Province, China, 2018–2023
- Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season
- Statewide Outbreak of Neisseria meningitidis Serogroup Y, Sequence Type 1466 — Virginia, 2022–2024
- Routine Vaccination Coverage — Worldwide, 2023
- Notes from the Field: Trichophyton mentagrophytes Genotype VII — New York City, April–July 2024
- QuickStats: Percentage of Adults Aged ≥18 Years Who Were in Families Having Problems Paying Medical Bills in the Past 12 Months, by Disability Status and Age Group — United States, 2023
October 24, 2024 / No. 42
- Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024
- Locally Acquired (Autochthonous) Mosquito-Transmitted Plasmodium vivax Malaria — Saline County, Arkansas, September 2023
- Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024
- Notes from the Field: First Locally Acquired Dengue Virus Infections — Pasadena, California, October–December 2023
October 17, 2024 / No. 41
- Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024
- Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024
- Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2023–24 School Year
- Notes from the Field: Enhanced Surveillance for Raccoon Rabies Virus Variant and Vaccination of Wildlife for Management — Omaha, Nebraska, October 2023–July 2024
- QuickStats: Prevalence of Obesity and Severe Obesity Among Persons Aged 2–19 Years — United States, 1999–2000 Through 2021–2023
October 10, 2024 / No. 40
- Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023
- Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults — United States, August 2022–July 2023
- Notes from the Field: Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024
- Notes from the Field: Suspected Outbreak of Trichinellosis Associated with Undercooked Bear Meat — North Carolina, November 2023
October 3, 2024 / No. 39
- Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization — REVELAC-i Network, Five South American Countries, March–July 2024
- COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024
- Differences in COVID-19 Outpatient Antiviral Treatment Among Adults Aged ≥65 Years by Age Group — National Patient-Centered Clinical Research Network, United States, April 2022–September 2023
- Burkholderia multivorans Infections Associated with Use of Ice and Water from Ice Machines for Patient Care Activities — Four Hospitals, California and Colorado, 2020–2024
- QuickStats: Rates of Emergency Department Visits for Children and Adolescents with Acute Upper Respiratory Infection, by Age Group — United States, 2021–2022
- COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months — COVID-NET, 12 States, October 2022–April 2024
- Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months — United States, April 2024
- Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 — National Immunization Survey-Child, United States, 2021–2023
- Vaccination Coverage by Age 24 Months Among Children Born During 2017–2021 — U.S.-Affiliated Pacific Islands
September 19, 2024 / No. 37
- Wastewater Surveillance for Influenza A Virus and H5 Subtype Concurrent with the Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in Cattle and Poultry and Associated Human Cases — United States, May 12–July 13, 2024
- Vital Signs: Suicide Rates and Selected County-Level Factors — United States, 2022
- Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024-2025
- Notes from the Field: Support for Wastewater Monitoring and Influence on Protective Behavioral Intentions Among Adults — United States, July 2024
- QuickStats: Percentage of Suicides and Homicides Involving a Firearm Among Persons Aged ≥10 Years, by Age Group — United States, 2022
September 12, 2024 / No. 36
- Progress Toward Achieving National HIV/AIDS Strategy Goals for Quality of Life Among Persons Aged ≥50 Years with Diagnosed HIV — Medical Monitoring Project, United States, 2017–2023
- Progress Toward Poliomyelitis Eradication — Pakistan, January 2023–June 2024
- Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
- Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024
September 5, 2024 / No. 35
- Contact Tracing for Mpox Clade II Cases Associated with Air Travel — United States, July 2021–August 2022
- Leptospirosis Outbreak in Aftermath of Hurricane Fiona — Puerto Rico, 2022
- Oropouche Virus Disease Among Travelers — United States, 2024
- Notes from the Field: E-Cigarette and Nicotine Pouch Use Among Middle and High School Students — United States, 2024
- QuickStats: Percentage of Children and Adolescents Aged ≤17 Years Who Used Telemedicine in the Past 12 Months, by Age Group and Year — United States, 2021–2023
- Cluster of Influenza A(H5) Cases Associated with Poultry Exposure at Two Facilities — Colorado, July 2024
- Changes in Health Indicators Among Caregivers — United States, 2015–2016 to 2021–2022
- Reported Non–Substance-Related Mental Health Disorders Among Persons Who Died of Drug Overdose — United States, 2022
- Notes from the Field: Intimate Partner Homicide Among Women — United States, 2018–2021
August 22, 2024 / No. 33
- National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023
- Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13–17 Years — U.S.-Affiliated Pacific Islands, 2013–2023
- Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility — National Immunization Survey-Child, United States, 2012–2022
- Notes from the Field: Tularemia Associated with Harbor Seal Necropsy — Kitsap County, Washington, October 2023
August 15, 2024 / No. 32
- Invasive Nontypeable Haemophilus influenzae Disease Outbreak at an Elementary School — Michigan, May 2023
- Use of Respiratory Syncytial Virus Vaccines for Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
- Notes from the Field: Universal Newborn Screening and Surveillance for Congenital Cytomegalovirus — Minnesota, 2023–2024
- Notes from the Field: Heightened Precautions for Imported Dogs Vaccinated with Potentially Ineffective Rabies Vaccine — United States, August 2021−April 2024
- Quickstats: Age-Adjusted Drug Overdose Death Rates, by State — United States, 2022
August 8, 2024 / No. 31
- Mortality in the United States — Provisional Data, 2023
- Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023
- Notes from the Field: Prevalence of Previous Dengue Virus Infection Among Children and Adolescents Aged 7–16 Years — American Samoa, September–October 2023
- Erratum: Vol. 72, No. RR-6
August 1, 2024 / No. 30
- Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015–April 2024
- Lead Poisoning in a Mother and Her Four Children Using a Traditional Eye Cosmetic — New York City, 2012–2023
- Notes from the Field: Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020–December 2023
- QuickStats: Percentage of Adult Day Services Centers That Use Any Telehealth, by U.S. Census Bureau Region — United States, 2022
- Adult Smoking Cessation — United States, 2022
- Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital — Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017–2022
- Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022
- Notes from the Field: Health Monitoring, Testing, and Case Identification Among Persons Exposed to Influenza A(H5N1) — Michigan, 2024
July 18, 2024 / No. 28
- Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination — Worldwide, 2000–2022
- Childhood Lead Exposure Linked to Apple Cinnamon Fruit Puree Pouches — North Carolina, June 2023–January 2024
- Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms — Charlottesville, Virginia, 2023–2024
- QuickStats: Percentage of Adults Aged ≥18 Years Who Walked for Transportation and Walked for Leisure in the Past 7 Days, by Urban-Rural Status — United States, 2022
July 11, 2024 / No. 27
- Human Case of Leptospirosis During a Canine Disease Outbreak — Wyoming, 2023
- Notes from the Field: Respiratory Viral Panel as an Early Diagnostic Tool for Neonatal Enterovirus Infection — San Diego, California 2023
- Notes from the Field: Illnesses After Administration of Presumed Counterfeit Botulinum Toxin in Nonmedical Settings — Tennessee and New York City, March 2024
- Erratum: Vol. 73, No. 21
July 4, 2024 / No. 26
- Reported Incidence of Infections Caused by Pathogens Transmitted Commonly Through Food: Impact of Increased Use of Culture-Independent Diagnostic Tests — Foodborne Diseases Active Surveillance Network, 1996–2023
- Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment — United States, July 2022–September 2023
- QuickStats: Age-Adjusted Death Rate Among Adults Aged ≥65 Years, by Sex — United States, 1970–2022
- Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
- Persistent Transmission of Circulating Vaccine-Derived Poliovirus — Somalia, January 2017–March 2024
- Notes from the Field: Multidisciplinary Approach to Investigating Brucella canis Exposures — South Carolina, September 2023
June 20, 2024 / No. 24
- Loneliness, Lack of Social and Emotional Support, and Mental Health Issues — United States, 2022
- Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak — Los Angeles County, June 2022–January 2023
- Emergency Medical Services Encounters for Firearm Injuries — 858 Counties, United States, January 2019–September 2023
- Findings from the First Year of a Federally Funded, Direct-to-Consumer HIV Self-Test Distribution Program — United States, March 2023–March 2024
- QuickStats: Percentage of Current Cigarette Smokers Aged ≥18 Years Who Received Advice from a Health Professional To Quit Smoking, by Sex and Age Group — United States, 2022
June 13, 2024 / No. 23
- Firearm Storage Behaviors — Behavioral Risk Factor Surveillance System, Eight States, 2021–2022
- Migration from Epi Info to District Health Information Software 2 for Vaccine-Preventable Disease Surveillance — World Health Organization African Region, 2019–2023
- Notes from the Field: Toxigenic Corynebacterium ulcerans in Humans and Household Pets — Utah and Colorado, 2022–2023
- Notes from the Field: Rapid Linkage of a Salmonella Livingstone Outbreak to a Restaurant, Using Open-Ended Interviews and Patient Purchase Histories — Utah, 2023–2024
June 6, 2024 / No. 22
- Mpox Surveillance Based on Rash Characteristics — 13 Emergency Departments, United States, June–December 2023
- Cases of Meningococcal Disease Associated with Travel to Saudi Arabia for Umrah Pilgrimage — United States, United Kingdom, and France, 2024
- Notes from the Field: Anthrax on a Sheep Farm in Winter — Texas, December 2023–January 2024
- QuickStats: Percentage of Adults Aged ≥25 Years Who Met the 2018 Federal Physical Activity Guidelines for Both Muscle-Strengthening and Aerobic Physical Activity, by Educational Attainment — United States, 2022
- Varicella Outbreak Among Recent Arrivals to New York City, 2022–2024
- West Nile Virus and Other Nationally Notifiable Arboviral Diseases — United States, 2022
- Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024
- State-Specific Hepatitis C Virus Clearance Cascades – United States, 2013–2022
- Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024
May 23, 2024 / No. 20
- Prevalence of Stroke — Behavioral Risk Factor Surveillance System, United States, 2011–2022
- Outbreak of Human Trichinellosis — Arizona, Minnesota, and South Dakota, 2022
- Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine — United States, May 2022–May 2024
- Vital Signs: Drowning Death Rates and Self-Reported Swimming Skill, Lesson Participation, and Recreational Water Exposure — United States, 2019–2023
- Notes from the Field: Clade II Mpox Surveillance Update — United States, October 2023–April 2024
May 16, 2024 / No. 19
- Measles Outbreak Associated with a Migrant Shelter — Chicago, Illinois, February–May 2024
- Real-Time Use of a Dynamic Model To Measure the Impact of Public Health Interventions on Measles Outbreak Size and Duration — Chicago, Illinois, 2024
- U.S. Preparedness and Response to Increasing Clade I Mpox Cases in the Democratic Republic of the Congo — United States, 2024
- Progress Toward Poliomyelitis Eradication — Worldwide, January 2022–December 2023
- QuickStats: Percentage Distribution of Deaths Involving Injuries from Recreational and Nonrecreational Use of Watercraft, by Month — United States, 2020–2022
May 9, 2024 / No. 18
- Shiga Toxin–Producing Escherichia coli O157:H7 Illness Outbreak Associated with Untreated, Pressurized, Municipal Irrigation Water — Utah, 2023
- Notes from the Field: Increases in Imported Malaria Cases — Three Southern U.S. Border Jurisdictions, 2023
- Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022
May 2, 2024 / No. 17
- Emergency Department Visits for Pedestrians Injured in Motor Vehicle Traffic Crashes — United States, January 2021–December 2023
- Cigarette Smoking Among Pregnant Women During the Perinatal Period: Prevalence and Health Care Provider Inquiries — Pregnancy Risk Assessment Monitoring System, United States, 2021
- Prevalence of Positive Childhood Experiences Among Adults — Behavioral Risk Factor Surveillance System, Four States, 2015–2021
- Notes from the Field: Increase in Nontoxigenic Corynebacterium diphtheriae — Washington, 2018–2023
- Erratum: Vol. 72, No. 29
- QuickStats: Percentage of Residential Care Communities That Use Electronic Health Records, by Community Bed Size — United States, 2018, 2020, and 2022
- Use of Ebola Vaccines — Worldwide, 2021–2023
- SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023
- Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023
- Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
- Notes from the Field: Group A Streptococcus Bacteremia in Persons Who Inject Drugs — Northern Vermont, January 2020–October 2023
- QuickStats: Percentage of Employed Adults Aged ≥18 Years Who Slept <7 Hours per 24-Hour Period, by Sex and Number of Working Hours per Week — United States, 2022
April 18, 2024 / No. 15
- Heat-Related Emergency Department Visits — United States, May–September 2023
- Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and
Adolescents — United States, 2021–2023 - COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024
- Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
- Vital Signs: Mammography Use and Association with Social Determinants of Health and Health-Related Social Needs Among Women — United States, 2022
- QuickStats: Percentage of Children and Adolescents Aged 3–17 Years Who Ever Received a Diagnosis of Autism Spectrum Disorder, by Family Income, 2020–2022
April 11, 2024 / No. 14
- Measles — United States, January 1, 2020–March 28, 2024
- State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2018–2022
- COVID-19 Vaccination Coverage — World Health Organization African Region, 2021–2023
- Infections Associated with Medtronic Duet External Ventricular Drains — Rhode Island Hospital, Providence, Rhode Island, January 2023–January 2024
- Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine — Oregon, June 2021–December 2022
- Notes from the Field: Neonatal Salmonellosis Associated with Backyard Poultry — Oregon, November 2023
April 4, 2024 / No. 13
- Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023
- Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023
- Notice to Readers: Change in Publication Date of QuickStats
- Erratum: Vol. 71, No. 19
- QuickStats: Life Expectancy at Birth, by Sex — United States, 2019–2022
- Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability — Sickle Cell Data Collection Program, 11 States, 2016–2020
- Ceftriaxone-Resistant Gonorrhea — China, 2022
- Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels — United States, May 2022–April 2023
- Tuberculosis — United States, 2023
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024
March 21, 2024 / No. 11
- Tuberculosis Preventive Treatment Update — U.S. President’s Emergency Plan for AIDS Relief, 36 Countries, 2016–2023
- Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic — United States, 2019–2021
- Notes from the Field: Expanded Laboratory Testing for Varicella — Minnesota, 2016–2023
March 14, 2024 / No. 10
- Outbreak Linked to Morel Mushroom Exposure — Montana, 2023
- Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023
- Notes from the Field: Measles Outbreak — Cook County, Illinois, October–November 2023
- Erratum: Vol. 72, No. 36
March 7, 2024 / No. 9
- Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults — United States, 2017–2021
- Years of Potential Life Lost and Mean Age of Adults Experiencing Nontraumatic, Out-of-Hospital Cardiac Arrests — Chicago, 2014–2021
- Racial and Ethnic Differences in Social Determinants of Health and Health- Related Social Needs Among Adults — Behavioral Risk Factor Surveillance System, United States, 2022
- Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
- Notes from the Field: Emergency Department Visits for Unsupervised Pediatric Melatonin Ingestion — United States, 2019–2022
- Deaths from Excessive Alcohol Use — United States, 2016–2021
- Progress Toward Rubella and Congenital Rubella Syndrome Elimination — Worldwide, 2012–2022
- Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
- Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza — California, October 2023–January 2024
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Chronic School Absenteeism Due to Illness, Injury, or Disability During the Past 12 Months, by Age Group and Year — National Health Interview Survey, United States, 2019 and 2022
February 22, 2024 / No. 7
- Progress Toward Measles Elimination — World Health Organization Eastern Mediterranean Region, 2019–2022
- Outbreak of Mycobacterium orygis in a Shipment of Cynomolgus Macaques Imported from Southeast Asia — United States, February–May 2023
- Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018–2024
- QuickStats: Percentage of Adults Aged ≥18 Years Who Lacked Reliable Transportation for Daily Living in the Past 12 Months, by Disability Status and Age Group — National Health Interview Survey, United States, 2022
February 15, 2024 / No. 6
- Surveillance for Lyme Disease After Implementation of a Revised Case Definition — United States, 2022
- Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022
- Hepatitis A Exposure Response and Outbreak Prevention in a Large Urban Jail — Los Angeles County, California, May–July 2023
- Notes from the Field: Long COVID Prevalence Among Adults — United States, 2022
- QuickStats: Percentage of Adults Aged ≥18 Years Who Were Advised During the Past 12 Months by a Doctor or Other Health Professional to Increase Their Amount of Physical Activity or Exercise, by Age Group and Sex — National Health Interview Survey, United States, 2022
February 8, 2024 / No. 5
- Characteristics of Alcohol, Marijuana, and Other Drug Use Among Persons Aged 13–18 Years Being Assessed for Substance Use Disorder Treatment — United States, 2014–2022
- Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance — United States, 2024
- Severe Work-Related Injuries in the Oil and Gas Extraction Industry — 32 Federal Occupational Safety and Health Administration Jurisdictions, United States, January 2015–July 2022
- Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023
- Notes from the Field: Rapidly Linking an Outbreak of Salmonella Typhimurium Infections to Domestically Grown Cantaloupes Through Early Collaboration — United States, 2022
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Urbanization Level and Age Group — National Health Interview Survey, United States, 2020–2022
February 1, 2024 / No. 4
- Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022
- Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
- Notes from the Field: Severe Vibrio vulnificus Infections During Heat Waves — Three Eastern U.S. States, July–August 2023
- Notes from the Field: Dengue Outbreak — Peru, 2023
Read this report en Español - Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
- QuickStats: Percentage of Newborns Breastfed Between Birth and Discharge from Hospital, by Maternal Age — National Vital Statistics System, 49 States and the District of Columbia, 2021 and 2022
- Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults — Behavioral Risk Factor Surveillance System, United States, 2013–2021
- Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 — Veterans Health Administration, March–September 2022
- Deaths of U.S. Citizens Undergoing Cosmetic Surgery — Dominican Republic, 2009–2022
- Notes from the Field: Nontuberculous Mycobacteria Infections After Cosmetic Surgery Procedures in Florida — Nine States, 2022–2023
- QuickStats: Percentage of Children and Adolescents Aged ≤17 Years Who Visited an Urgent Care Center or a Clinic in a Drug Store or Grocery Store in the Past 12 Months, by Age Group and Year — National Health Interview Survey, United States, 2021–2022
January 18, 2024 / No. 2
- Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021
- Pseudomonas Infection Outbreak Associated with a Hotel Swimming Pool — Maine, March 2023
- Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023
- Mpox Outbreak — Los Angeles County, California, May 4–August 17, 2023
- QuickStats: Percentage of Adults Aged ≥18 Years with Diagnosed Diabetes, by Urbanization Level and Age Group — National Health Interview Survey, United States, 2022
January 11, 2024 / No. 1
- Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024
- Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19–Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease — United States, September 2022–March 2023
- Notice to Readers: Change in Publication Date of MMWR Series
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Been the Victim of Violence or Witnessed Violence in Their Neighborhood, by Disability Status and Age Group — National Health Interview Survey, United States, 2022